Ferritin is closely associated with microglia in amyotrophic lateral sclerosis

Ju Gao1, Ogoegbunam Okolo2, Sandra L Siedlak2

  • 1Department of Pharmacology and Toxicology, University of Arizona, Tucson, AZ, United States.

Insights

Iron accumulation and increased ferritin, a protein that binds iron, are linked to amyotrophic lateral sclerosis (ALS) progression. These changes are associated with activated microglia in affected brain and spinal cord areas.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Iron deposition is a key feature of amyotrophic lateral sclerosis (ALS).
  • Iron dysregulation affects ferritin levels, a key iron-binding protein.
  • Oxidative stress contributes to iron dysregulation in ALS.

Purpose of the Study:

  • To investigate the relationship between iron deposition, ferritin, and microglial activation in ALS.
  • To examine ferritin and microglial changes in spinal cord and cerebral cortex tissues of ALS patients and a mouse model.

Main Methods:

  • Immunohistochemical analysis of spinal cord and cerebral cortical tissues from ALS patients and control subjects.
  • Examination of spinal cord tissues from SOD1G93A transgenic mice.
  • Biochemical fractionation to analyze ferritin levels in insoluble protein fractions.

Main Results:

  • Increased ferritin immunostaining and microgliosis were observed in white matter axons of ALS spinal cords.
  • Gray matter motor neurons also showed increased ferritin and microglia, but to a lesser extent than white matter.
  • Ferritin was associated with microglia in ALS cortical tissues and SOD1G93A mouse spinal cords.
  • Elevated ferritin levels were found in the insoluble fraction of ALS spinal cord tissues.

Conclusions:

  • Activated microglia and increased ferritin are closely associated in degenerating areas of the central nervous system in ALS.
  • These findings suggest a significant role for ferritin and microglia in ALS pathogenesis and progression.
  • Further research into iron regulation and microglial pathways may offer therapeutic targets for ALS.